Urea

Urea

SCHEMBL7756359

NC(N)=O.NC(N)=O.NC(N)=O

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 6/20 1.00
ALDH1A1 P00352 4/20 1.00
TDP1 Q9NUW8 3/20 1.00
OR51E2 Q9H255 2/20 1.00
ACHE P22303 1/20 0.62
BLM P54132 4/20 0.56
PMP22 Q01453 3/20 0.56
ALOX15 P16050 3/20 0.56
LDHA P00338 2/20 0.50
LDHB P07195 1/20 0.50
TSHR P16473 4/20 0.46
CYP3A4 P08684 3/20 0.46
NFKB1 P19838 2/20 0.46
HPGD P15428 2/20 0.46
HSD17B10 Q99714 2/20 0.46
CYP1A2 P05177 2/20 0.46
THPO P40225 2/20 0.46
CA2 P00918 2/20 0.46
CA9 Q16790 2/20 0.46
EHMT2 Q96KQ7 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Urea SCHEMBL30788720 1.00
Urea C 13 SCHEMBL12476878 1.00
Urea SCHEMBL30692613 1.00
Urea SCHEMBL8560069 1.00 LMNA (1.00) LMNAALDH1A1TDP1OR51E2ACHE
Urea SCHEMBL8434002 1.00 LMNA (1.00) LMNAALDH1A1TDP1OR51E2ACHE
Urea SCHEMBL187990 1.00
Urea SCHEMBL8436158 1.00 LMNA (1.00) LMNAALDH1A1TDP1OR51E2ACHE
Urea SCHEMBL411583 1.00
Urea SCHEMBL20641124 1.00 LMNA (1.00) LMNAALDH1A1TDP1OR51E2ACHE
Urea SCHEMBL30111758 1.00

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024058984-A2 METHODS AND USES OF MICROBIOME COMPOSITIONS, COMPONENTS, OR METABOLITES FOR TREATING INSULIN-ASSOCIATED DISEASES MarvelBiome, Inc. (US) 2024-03-21 WO disclosed
EP-3652133-A1 MIXTURES COMPRISING AN UREASE INHIBITOR (UI) AND A NITRIFICATION INHIBITOR SUCH AS 2-(3,4-DIMETHYL-1H-PYRAZOL-1-YL)SUCCINIC ACID (DMPSA) OR 3,4-DIMETHYL PYRAZOLIUM GLYCOLATE (DMPG) BASF SE (DE) 2020-05-20 EP disclosed
WO-2019012382-A1 MIXTURES COMPRISING AN UREASE INHIBITOR (UI) AND A NITRIFICATION INHIBITOR SUCH AS 2-(3,4-DIMETHYL-1H-PYRAZOL-1-YL)SUCCINIC ACID (DMPSA) OR 3,4-DIMETHYL PYRAZOLIUM GLYCOLATE (DMPG) BASF SE (DE) 2019-01-17 WO disclosed
EP-1090059-A1 TERTIARY AMINE POLYAMIDOAMINE-EPIHALOHYDRIN POLYMERS HERCULES INCORPORATED (US) 2001-04-11 EP disclosed
EP-1062102-A1 A BOOKBINDING PROCESS National Starch and Chemical Investment Holding Corporation (US) 2000-12-27 EP disclosed
US-6111032-A REACTING TERTIARYAMINE POLYAMIDOAMINE PREPOLYMER AND AN EPIHALOHYDRIN WITH A MOLAR RATIO OF EPIHALOHYDRIN AND TERTIARY AMINE OF POLYAMIDOAMINE PREPOLYMER OF LESS THAN 1:1, PH ALKALINE 7.5 TO 9, IN PRESENCE OF NONHALIDE ACID HERCULES INCORPORATED (US) 2000-08-29 US disclosed
CN-1244801-A Sulfonylurea-glitazone synergistic combinations for diabetes WARNER LAMBERT CO (US) 2000-02-16 CN disclosed
WO-1999057175-A1 TERTIARY AMINE POLYAMIDOAMINE-EPIHALOHYDRIN POLYMERS HERCULES INCORPORATED (US) 1999-11-11 WO disclosed
WO-1999048698-A1 A BOOKBINDING PROCESS NATIONAL STARCH & CHEMICAL INVESTMENT HOLDING CORPORATION (US) 1999-09-30 WO disclosed